| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMAOPHTHALMOL.2017.0255 |
| P8608 | Fatcat ID | release_bp6wklqzuzfubfyej2asjmdm6i |
| P932 | PMC publication ID | 5470421 |
| P698 | PubMed publication ID | 28358948 |
| P2093 | author name string | Nadim Rayess | |
| John S Wittenborn | |||
| Carl Regillo | |||
| Traci Clemons | |||
| David Rein | |||
| Danielle Liffmann Kruger | |||
| P2860 | cites work | Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results | Q24633874 |
| Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
| Prevalence of patients presenting with neovascular age-related macular degeneration in an urban population | Q33213554 | ||
| The burden of age-related macular degeneration | Q33239452 | ||
| Systematic review of home telemonitoring for chronic diseases: the evidence base | Q33276101 | ||
| Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting | Q33455256 | ||
| Resource utilization and costs of age-related macular degeneration. | Q34328499 | ||
| Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration | Q34437164 | ||
| A simplified severity scale for age-related macular degeneration: AREDS Report No. 18 | Q34655498 | ||
| Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study | Q34659554 | ||
| The significance of early detection of age-related macular degeneration: Richard & Hinda Rosenthal Foundation lecture, The Macula Society 29th annual meeting | Q34692245 | ||
| Health care economic analyses and value-based medicine | Q35103628 | ||
| Medicare costs for neovascular age-related macular degeneration, 1994-2007. | Q35560661 | ||
| Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study | Q37570185 | ||
| Is the United States ready for QALYs? | Q37593864 | ||
| Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial | Q38009430 | ||
| Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration | Q43274861 | ||
| Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK. | Q44558337 | ||
| Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration | Q44798804 | ||
| Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). | Q46102122 | ||
| Causes and prevalence of visual impairment among adults in the United States | Q46890945 | ||
| The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration | Q50647355 | ||
| Quality of life associated with unilateral and bilateral good vision | Q73738825 | ||
| Toward consistency in cost-utility analyses: using national measures to create condition-specific values | Q74660492 | ||
| What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? | Q80944346 | ||
| Socio-economic deprivation and visual acuity at presentation in exudative age-related macular degeneration | Q83012166 | ||
| Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1 | Q87298378 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macular degeneration | Q27429789 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 452-459 | |
| P577 | publication date | 2017-05-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System | |
| P478 | volume | 135 |
| Q60923327 | Artificial intelligence-based decision-making for age-related macular degeneration |
| Q99212624 | Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective |
| Q101476469 | Optical coherence tomography in the 2020s-outside the eye clinic |
| Q90626152 | Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition |
| Q90539652 | Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring |
| Q90626155 | Telemedicine for Age-Related Macular Degeneration |
Search more.